0001193125-15-351076.txt : 20151023 0001193125-15-351076.hdr.sgml : 20151023 20151022213800 ACCESSION NUMBER: 0001193125-15-351076 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20151022 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151023 DATE AS OF CHANGE: 20151022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 151171445 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 d53866d8k.htm 8-K 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

 

Date of Report: October 22, 2015

(Date of earliest event reported)

 

 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091
(State of Incorporation)  

(Commission

File Number)

 

(IRS Employer

Identification Number)

1445 Ross Avenue, Suite 1400

Dallas, Texas 75202

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On October 22, 2015, Tenet Healthcare Corporation (the “Company”) issued a press release reporting certain information regarding the Company’s previously announced financial outlook for the quarter ended September 30, 2015. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in the press release filed as an exhibit to this report constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements are based on management’s current expectations and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from those expressed or implied by such forward-looking statements. Such factors include, among others, the following: the future impact of healthcare reform legislation, the enactment of additional federal and state healthcare reform, and the related effect on reimbursement and utilization and the future designs of provider networks and insurance plans, including pricing, provider participation, coverage, co-pays and deductibles; other changes in federal, state and local laws and regulations affecting the healthcare industry; general economic and business conditions, both nationally and regionally; adverse litigation or regulatory developments; the ability to enter into managed care provider arrangements on acceptable terms; cuts to Medicare and Medicaid payment rates or changes in reimbursement practices; competition; our success in implementing our business development plans; our ability to hire and retain qualified personnel; the availability and terms of capital to fund the expansion of our business, including the acquisition of additional facilities; our success in marketing the revenue cycle management, healthcare information management, management services, and patient communications and engagement services businesses under our Conifer Health Solutions subsidiary; our ability to fully realize the anticipated benefits and synergies of our acquisitions and to successfully complete the integration of businesses we acquire, including our United Surgical Partners International joint venture; our ability to identify and execute on measures designed to save or control costs or streamline operations; the impact of our significant indebtedness; our success in operating our health plans and accountable care networks; and our success in completing recently announced acquisition and disposition transactions. These and other risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q. All information in this report and the press release is as of October 22, 2015. The Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

99.1    Press Release issued on October 22, 2015

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TENET HEALTHCARE CORPORATION
By:  

/s/ Daniel J. Cancelmi

  Daniel J. Cancelmi
  Chief Financial Officer

Date: October 22, 2015

 

3


EXHIBIT INDEX

 

99.1    Press Release issued on October 22, 2015

 

4

EX-99.1 2 d53866dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

 

LOGO

Tenet Reaffirms Adjusted EBITDA Outlook for the Third Quarter Ended September 30, 2015

DALLAS – October 22, 2015 – In light of the extraordinary volatility of its shares in recent days, Tenet Healthcare Corporation (NYSE:THC) is reaffirming its previously announced Adjusted EBITDA Outlook for the third quarter ended September 30, 2015 in the range of $550 million to $600 million.

As previously announced, the company plans to report its results for the third quarter after the market close on Monday, November 2, 2015. The company’s financial results are subject to finalization of the company’s quarterly financial and accounting procedures.

The company will host a conference call on Tuesday, November 3, 2015, at 10:00 a.m. ET (9:00 a.m. CT) for management to discuss the results. A live audio webcast will be accessible through the company’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Tenet Healthcare Corporation is a diversified healthcare services company with more than 130,000 employees united around a common mission: to help people live happier, healthier lives. Through its subsidiaries, partnerships and joint ventures, including United Surgical Partners International (USPI), the company operates 87 general acute care hospitals, 19 short-stay surgical hospitals and over 440 outpatient centers in the United States, as well as nine facilities in the United Kingdom. Tenet’s Conifer Health Solutions subsidiary provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks (IDN), physician groups, self-insured organizations and health plans. For more information, please visit www.tenethealth.com.

The terms “THC”, “Tenet Healthcare Corporation”, “the company”, “we”, “us” or “our” refer to Tenet Healthcare Corporation or one or more of its subsidiaries or affiliates as applicable.

###

 

Corporate Communications

Charles Nicolas

469-893-2640

mediarelations@tenethealth.com

 

Investor Relations

Brendan Strong

469-893-6992

investorrelations@tenethealth.com

 

Page 1


This release contains “forward-looking statements” – that is, statements that relate to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as “expect,” “assume,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include, but are not limited to, the factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2014 and other filings with the Securities and Exchange Commission. The information contained in this release is as of the date hereof. The company assumes no obligation to update forward-looking statements contained in this release as a result of new information or future events or developments.

Tenet uses its company website to provide important information to investors about the company including the posting of important announcements regarding financial performance and corporate developments.

 

Page 2

GRAPHIC 3 g53866img001.jpg GRAPHIC begin 644 g53866img001.jpg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end